We have yet to receive a reply but will keep you updated
Semaglutide is a modified analog designed to last much longer in the body
(Hurley & Frier, 2025) For patients, this means the first question to ask of any provider offering peptide therapy isn't "do you offer peptides" but "how are you sourcing them and what is the current regulatory status of each compound you prescribe?" A provider still listing Category 2 compounds as standard menu offerings without discussing compounding compliance is telling you something important about their regulatory literacy
BPC-157 Peptide Therapy: What Is It and What Are the Benefits
Doctronic, the #1 AI Doctor, offers you a smarter, faster, and more personal healthcare experience
All known effects discussed here are derived from laboratory models, and careful interpretation is essential when considering relevance to human biology